Marcus O. Butler

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial”.

Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial

Nature Medicine(2023)10.1038/s41591-022-02128-z

N/A

5.6DataRank · unranked

197 citations

Brian A. Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L. Johnson, Anthony J. Olszanski +39 more

Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results

Nature Medicine(2023)10.1038/s41591-023-02452-y

N/A

2.2DataRank · unranked

106 citations

Marcus O. Butler, Roisin E. O’Cearbhaill, David Y. Oh, Melissa L. Johnson, Kevin Zikaras +10 more

Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors

Frontiers in Oncology(2022)10.3389/fonc.2022.818679

N/A

0.830DataRank · unranked

20 citations

Marcus O. Butler, Russell K. Pachynski, Ryan J. Sullivan, Partow Kebriaei, Sarah Boross-Harmer +20 more

Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target

Melanoma Research(2020)10.1097/cmr.0000000000000701

N/A

0.757DataRank · unranked

14 citations

Oliver Surriga, Daniel J. Olson, Jacob B. Allred, Carrie Strand, Yuanyuan Zha +11 more

PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma

Nature Communications(2020)10.1038/s41467-020-19810-w

N/A

0.675DataRank · unranked

89 citations

Alain P. Algazi, Paolo A. Ascierto, Marcus O. Butler, Sunandana Chandra, Michael S. Gordon +10 more

Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy

Nature Immunology(2022)10.1038/s41590-022-01262-7

N/A

0DataRank · unranked

52 citations

Ramy Gadalla, Heidi Elsaesser, Diala Abd-Rabbo, Rene Quevedo, S.Y. Cindy Yang +19 more

Supplementary Table 1, Figures 1 - 3 from Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy

Figshare(2023)10.1158/2326-6066.22537889

N/A

0DataRank · unranked

0 citations

Munehide Nakatsugawa, Kenji Chamoto, Shinya Tanaka, Yuki Yamashita, Tingxi Guo +5 more

Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008735

N/A

0DataRank · unranked

79 citations

Omid Hamid, Krishna V. Komanduri, Rodabe N. Amaria, Marcus O. Butler, John B.A.G. Haanen +6 more